Multispan
Company

Last deal

$600.K

Amount

Series B

Stage

01.10.2007

Date

2

all rounds

$1.1M

Total amount

General

About Company
Multispan is a biotech company focused on drug discovery research targeting G protein-coupled receptors (GPCRs).

Industry

Sector :

Subsector :

founded date

01.01.2004

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

Multispan has developed the industry's largest collection of human GPCR clones and GPCR-expressing cell lines for HTS, including the proprietary HExTM series of High Expression cell lines. In addition to drug discovery research, Multispan offers custom compound profiling, cell line generation, antibody development, and frozen cell and membrane preparation, with scientific consultations from assay design to implementation. The company's assay tools for research applications and GPCR therapeutic antibody leads for inflammatory diseases and cancer have earned successful long-term collaborations with a wide range of leading pharmaceutical and biotech companies globally.
Contacts

Phone number

Social url